Since DNMT3A-R882 mutations were increased in the short-lived group, we analyzed if mutations of FLT3 or/and NPM1 are found more frequently in AML patients with DNMT3A-R882 mutations compared to patients with other DNMT3A mutations. The gene discussed is NPM1; the disease is acute myeloid leukemia.